News blog

Updates from Europe PMC, a global database of life sciences literature

Europe PMC team

 | 6 December 2010


Submission fees – a viable business model for Open Access publishing

A new study commissioned by the Knowledge Exchange argues that there can be benefits to publishers if they switch to a model based on submission fees.

The report “Submission fees – A tool in the transition to Open Access?”, written by Mark Ware, concludes that this model could be particularly relevant to journals with a high rejection rate.  They could combine submission fees with article processing charges in order to make the transition to open access easier.

The model has attracted interest but publishers regard the risks, particularly those involved in any transition, as outweighing the perceived benefits.  To support any transition, funders, institutions and publication funds could explicitly allow submission fees as a cost as this is often unclear in their policies.

This new study draws on research (conducted SQW Ltd on behalf of the Wellcome Trust), which also concluded that submission fees could play a key role in helping publishers transition to an open access model.

When a publisher offer a Wellcome-compliant open access model (i.e. deposition of the final paper in PMC/UKPMC at the time of publication, and a licence which allows the work to be re-used), then publisher submission fees are an allowable expense.

Post a comment

I agree to the limited use of my personal data as described in the Europe PMC advanced user services privacy policy.

Creative Commons Licence
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Subscribe to the Europe PMC News blog to receive the latest updates

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Partnerships & funding

Europe PMC is a service of the Europe PMC Funders' Group, in partnership with EMBL’s European Bioinformatics Institute (EMBL-EBI); and in cooperation with the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NCBI/NLM) . It includes content provided to the PubMed Central (NLM/PMC) archive by participating publishers.